People battling rifampicin-resistant tuberculosis (RR-TB) could soon have access to a shorter and safer course of treatment. Doctors without Borders (MSF) have released the results from a clinical trial on an all oral six-month treatment regime. Current treatment can last almost two years and can include painful injections and taking up to 20 pills a […]